HDX
DEAD

Serial Number

86370488

Owner

HORIZON DISCOVERY LIMITED

Attorney

Mark Harrison

Filing Date

Aug 19, 2014

Add to watchlist:

No watchlists yet
View on USPTO

HDX Trademark

Serial Number: 86370488

HDX is a trademark filed by HORIZON DISCOVERY LIMITED on August 19, 2014. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

HORIZON DISCOVERY LIMITED (24 trademarks)

8100 CAMBRIDGE RESEARCH PARK
WATERBEACH, CAMBRIDGE CB259TL , GB

Entity Type: 99

Trademark Details

Filing Date

August 19, 2014

Registration Date

Not Registered

Goods & Services

Custom cell-line engineering services; scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modelling services, gene engineering services, establishing patient genotypes; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; pharmaceutical research, namely, identification of patient-relevant drug targets, optimisation of drug candidates for clinical development; diagnostic services; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; research and development services relating to combining therapies for individuals; research and development relating to reagents; scientific research in the field of disease modelling; medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 9, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 9, 2015 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 11, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 11, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 11, 2014 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2014 DOCK
AMENDMENT FROM APPLICANT ENTERED
Dec 3, 2014 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2014 CRFA
ASSIGNED TO LIE
Nov 25, 2014 ALIE
PAPER RECEIVED
Nov 21, 2014 MAIL
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2014 NWOS
NEW APPLICATION ENTERED
Aug 22, 2014 NWAP